Insider Transactions in Q3 2023 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,115
-0.13%
|
$112,095
$53.22 P/Share
|
|
Sep 15
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
260,894
-14.05%
|
$13,827,382
$53.16 P/Share
|
|
Sep 14
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
94,440
-4.84%
|
$5,005,320
$53.05 P/Share
|
|
Sep 11
2023
|
Joanne Bryce Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+39.94%
|
$22,500
$9.86 P/Share
|
|
Sep 01
2023
|
Joanne Bryce Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-44.25%
|
$52,000
$52.99 P/Share
|
|
Sep 01
2023
|
Joanne Bryce Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+30.67%
|
$2,000
$2.65 P/Share
|
|
Aug 21
2023
|
William Jacob Savage Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$6,000
$2.65 P/Share
|
|
Aug 15
2023
|
Kevin Bitterman |
SELL
Open market or private sale
|
Indirect |
72,931
-7.64%
|
$3,792,412
$52.4 P/Share
|
|
Aug 15
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
72,931
-7.64%
|
$3,792,412
$52.4 P/Share
|
|
Aug 15
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
111,069
-5.39%
|
$5,775,588
$52.4 P/Share
|
|
Aug 15
2023
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,672
-67.31%
|
$406,616
$53.16 P/Share
|
|
Aug 14
2023
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
175,000
-2.66%
|
$9,275,000
$53.27 P/Share
|
|
Aug 09
2023
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,269
-21.47%
|
$413,450
$50.01 P/Share
|
|
Aug 01
2023
|
Joanne Bryce Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,521
-53.31%
|
$226,050
$50.07 P/Share
|
|
Aug 01
2023
|
Joanne Bryce Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,521
+43.88%
|
$4,521
$1.01 P/Share
|